My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
June/July 2013
Top Stories
All Baby Boomers Should Be Screened for HCV, U.S. Task Force Concludes
HCV resources can help IDSA members educate primary care providers

All adults born between 1945 and 1965 should be screened once for hepatitis C virus (HCV) infection, according to final screening recommendations issued by the U.S. Preventive Services Task Force in late June, strengthening an earlier draft recommendation for this screening among baby boomers.

In late 2012, IDSA and other organizations had strongly urged (PDF) the task force to upgrade its initial draft recommendation, which fell short of guidance from the Centers for Disease Control and Prevention (CDC)—supported by IDSA—that all baby boomers be screened. The task force’s stronger final recommendation is now consistent with CDC’s guidance, a move IDSA welcomed in a statement. In addition to influencing medical practice, the task force’s recommendations are also used by private and public insurers in determining which screening services are covered.

As a service to members interested in outreach to their primary care partners, IDSA is offering a one-time mailing to announce the new HCV screening recommendation. Members can submit up to 25 primary care office addresses that will receive a customized letter promoting the screening recommendation and identifying the IDSA member as a provider of HCV care.  Alternatively, members can send the customized letter directly to primary care providers themselves.

The letter is intended to foster appropriate care coordination for patients diagnosed with HCV infection between their primary care provider and their ID physician. Visit IDSA’s website for more information (scroll down to “HCV Screening Letter”).

The Society also recently launched a free, monthly webinar series, the IDSA Hepatitis C Knowledge Network, to educate members about current recommended practices to effectively identify, treat, and manage patients infected with HCV. Each hour-long webinar, hosted by HCV experts on topics developed by IDSA’s Hepatitis Task Force, includes a lecture portion, case studies, and a question-and-answer period.

Archived versions of the first two webinars, on appropriate HCV screening/testing and medical management, are available online (you must be logged in to access this link). For more information about the webinars, including topics, presenters, dates, and how to register, as well as access to archived webinars as they become available, visit IDSA’s website (member login required).

Additional clinical and educational resources for ID physisians interested in treating patients infected with HCV are available at www.idsociety.org/Hepatitis_C, including a Hepatitis C Management Discussion Board. Join today and become a part of the community of HCV treatment professionals. You can engage experts in the treatment of HCV and exchange information with your peers about HCV treatment, management, and complications.

Don’t miss these HCV-related sessions at IDWeek, Oct. 2-6, in San Francisco:

For a complete listing of current speakers and topics, check out the IDWeek interactive program planner.


How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
New Guide for Laboratory Diagnosis of Infectious Diseases Now Available
ACIP: Evidence Doesn’t Support Second Dose of Tdap Vaccine for Adolescents and Adults
New Tools for Preventing Bloodstream Infections in Dialysis Patients
CDC Issues H3N2v Health Advisory with Updates for 2013
Clinical Practice Management
FDA Clarifies IND Requirement for Fecal Microbiota Transplantation
Science Speaks Blog
Advocates, Physicians Urge Company to Increase Access to New TB Drug
High Court Strikes Down “Anti-Prostitution Pledge” for Global AIDS Funding
Turning 10, PEPFAR Celebrates a Million Lifetimes of Birthdays to Come
Policy and Advocacy
Critical Antimicrobial Resistance Legislation Reintroduced in Congress
IDSA, PIDS Call for Broad Federal Response to Pertussis Outbreak
HHS Issues Organ Transplant Guidelines for Preventing Disease Transmission
Your Colleagues
In Memoriam: Alan D. Tice, MD, FIDSA (1943-2013)
Check Out “My IDSA” for Latest Member News
Education & Resources
Editor-in-Chief Applicants Sought for New IDSA/HIVMA Journal
Updated Journals App for iPhone, iPod Touch, or iPad
Top Stories
From the President: Diagnostic Advances Offer Great Promise for Patient Care, Public Health
All Baby Boomers Should Be Screened for HCV, U.S. Task Force Concludes
EIN Update: Asymptomatic Bacteriuria and Antimicrobial Stewardship
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.